Here’s what you need to know:
1. Janssen Biotech is a biotechnology company headquartered in Horsham, Pa.
2. Miraca Life Sciences is a medical laboratory based in Irving, Texas. This collaboration utilizes the company’s InformTx therapeutic drug monitoring service.
3. The Janssen 2Inform program provides IBD patients using Remicade treatment with two free therapeutic drug monitoring blood tests each year, even if they are not covered by insurance.
4. These tests will be analyzed by Miraca Life Sciences and reported back to the physician.
5. This program aims to help healthcare providers better evaluate how a patient is responding to Remicade.
More articles on gastroenterology and endoscopy:
Patient-targeted CRC websites vary in accuracy, readability: 5 study insights
Florida Hospital Center for Interventional Endoscopy adopts Cellvizio System: 4 notes
Case Western researchers study Crohn’s with $9.7M renewal grant: 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
